Galectin Therapeutics Inc Earnings

The next earnings date for Galectin Therapeutics Inc is August 12, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Galectin Therapeutics Inc Earnings

Report DateEstimated Earnings Per Share
08/12/2026$-0.09

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Galectin Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/15/2026Before Market$-0.08-30.72%
03/31/2026Before Market$-0.0821.57%
11/14/2025Before Market$-0.13-15.86%
08/14/2025Before Market$-0.1226.47%
05/15/2025Before Market$-0.1526.47%
03/31/2025Before Market$-0.19-16.42%
11/14/2024Before Market$-0.1811.76%
08/13/2024Before Market$-0.20-22.55%
05/15/2024Before Market$-0.19-16.42%
03/29/2024Before Market$-0.161.96%
11/13/2023Before Market$-0.24-47.06%
08/14/2023Before Market$-0.1529.97%
05/15/2023Before Market$-0.1911.30%
03/30/2023Before Market$-0.18-3.81%
11/14/2022Before Market$-0.1431.37%
08/15/2022Before Market$-0.1617.44%
05/16/2022Before Market$-0.17-19.05%
03/31/2022Before Market$-0.1238.08%
11/15/2021Before Market$-0.1423.75%
08/16/2021Before Market$-0.1423.75%
05/17/2021Before Market$-0.1136.56%
03/31/2021Before Market$-0.1320.34%
11/09/2020Before Market$-0.1029.97%
08/10/2020Before Market$-0.11-13.52%
05/11/2020Before Market$-0.0634.64%
03/16/2020Before Market$-0.12-96.08%
11/12/2019Before Market$-0.0542.33%
08/09/2019Before Market$-0.0650.98%
05/10/2019Before Market$-0.20-40.06%
03/06/2019Before Market$-0.081.96%
11/13/2018Before Market$-0.0723.75%
08/14/2018Before Market$-0.116.22%
05/11/2018After Market$-0.129.50%
03/29/2018Before Market$-0.0739.45%
11/07/2017Before Market$-0.138.96%
08/14/2017Before Market$-0.148.50%
05/15/2017Before Market$-0.155.12%
03/28/2017Before Market$-0.1230.80%
11/08/2016Before Market$-0.1914.03%
08/09/2016Before Market$-0.2019.42%
05/10/2016Before Market$-0.24-38.41%
03/15/2016Before Market$-0.1915.33%
11/09/2015Before Market$-0.26-27.45%
08/10/2015Before Market$-0.2110.49%
05/11/2015Before Market$-0.22-7.84%
03/18/2015After Market$-0.18-3.81%
11/10/2014Before Market$-0.1737.11%
08/07/2014After Market$-0.1720.63%
05/13/2014After Market$-0.25-22.55%
03/21/2014After Market$-0.1516.76%
11/12/2013Before Market$-0.22-10.61%
08/14/2013After Market$-0.184.61%
05/10/2013After Market$-0.22-19.83%
03/31/2013After Market$-0.1720.63%
11/09/2012After Market$-0.19-3.49%
08/10/2012After Market$-0.19-16.42%
03/30/2012---$-0.29-35.39%
11/10/2011After Market$-0.1826.47%
08/12/2011Before Market$-0.36-96.08%
11/14/2007Before Market$-0.36-Infinity%
08/10/2007Before Market$0100.00%

More About Galectin Therapeutics Inc

Website
https://galectintherapeutics.com
Country
USA
Full Time Employees
9

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in a Phase 2 clinical study in MASH patients with advanced fibrosis and a second Phase 2b clinical trial in MASH patients with compensated cirrhosis and portal hypertension. It has a joint venture co-owned by SBH Sciences, Inc. to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

“Galectin Therapeutics Inc Earnings” Can Refer to the Galectin Therapeutics Inc Earnings Date

Some people say “Galectin Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Galectin Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Galectin Therapeutics Inc Stock on the Earnings Date

If you own Galectin Therapeutics Inc stock (GALT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Galectin Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Galectin Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Galectin Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Galectin Therapeutics Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.